Blog

Stellar talks from pioneering generation of haematologists at EHA2024 – Guezguez lab

Photo taken from Guezguez lab/X

Jun 21, 2024, 13:21

Stellar talks from pioneering generation of haematologists at EHA2024 – Guezguez lab

Guezguez lab shared a post on X:

“And it’s a wrap for another fantastic European Hematology Association (EHA) 2024 with stellar Clonal Hematopoiesis of Indeterminate Potential (CHIP), Myelodysplasia Syndrome (MDS), Acute Myeloid Leukaemia (AML) talks from pioneering and new generation of hematologists. A great occasion to catch up with friends, colleagues and initiate new collaborations even managed to tag along with my previous PhD supervisor Thierry Jaffredo, Institute of Biology Paris Seine. Garcias.”

Source: Guezguez lab/X

Acute Myeloid Leukaemia ASCO cancer Clonal Hematopoiesis of Indeterminate Potential EHA2024 Guezguez lab Institute of Biology Paris Seine Myelodysplasia syndrome OncoDaily Oncology Thierry Jaffredo

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage